SA
Sign upLog In

Regeneron Pharmaceuticals (REGN)

Revenue

$5.12B

Quarterly · Period ending: · USD

REGN logo

REGN Revenue

Latest reported$5.12B
REGN Quarterly Revenue ($1.20M → $5.12B)
High-resolution chart · PNG

REGN revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals Revenue — Quarterly (USD)
Period endingRevenue (USD)
5,480,000
5,779,000
9,085,000
19,416,000
14,906,000
14,456,000
10,498,000
11,900,000
11,300,000
5,900,000
5,500,000
7,400,000
10,800,000
13,500,000
6,500,000
11,400,000
8,900,000
6,600,000
6,200,000
6,500,000
6,200,000
6,200,000
5,200,000
5,800,000
6,200,000
7,600,000
6,900,000
7,700,000
8,900,000
3,600,000
3,000,000
2,900,000
3,600,000
1,300,000
2,100,000
2,300,000
2,400,000
3,200,000
3,500,000
2,000,000
1,900,000
1,700,000
2,000,000
1,300,000
1,300,000
1,200,000
1,200,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.